The "Technology Landscape, Trends and Opportunities in Massive Open Online Course (Mooc) Market" has been added to ResearchAndMarkets.com's offering. The technologies in the massive open online course ...
Chlorpyrifos has undergone dramatic changes in its market trajectory, from a blockbuster proprietary molecule to a globally traded generic active ingredient. AgriBusiness Global spoke with Ram ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...
“The smart move for both sides is to demand coherent, predictable rules. That means backing MSN’s petition on the legal question and forcing the Supreme Court to choose between the Idenix line and the ...
The doubloons, dollars and denarii of the American Numismatic Society will leave their overlooked home in Manhattan for a more welcoming headquarters on the campus of the Toledo Museum of Art. The ...
ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...
We may receive commissions from some links to products on this page. Promotions are subject to availability and retailer terms. These two phases often get lumped together in conversations about debt, ...
Pity the Romans. Their sculpture is often compared unfavorably to that of the Greeks. While the work of their Attic cousins is celebrated for being high-minded and idealistic—all those ripped bodies, ...
Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...
Entresto generics have finally arrived in the U.S. in July, and approximately 9% of Novartis' revenue will be impacted. The growth of other key products and of Entresto in ex-U.S. territories should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback